logo

Inhibikase Therapeutics Inc Inc. (IKT) Price Performance Over the Years: A Comparative Study

HCCC Stock

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -40.92%.However, over the last six months, we can see a weaker performance of 33.33%. Over the last 30 days, the price of IKT has leaped by -37.05%. And in the last five days, it has fallen by -32.16%.

Inhibikase Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $4.20 on 12/18/24, with the lowest value being $1.12 on 09/25/24.

52-week price history of IKT Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Inhibikase Therapeutics Inc’s current trading price is -54.29% away from its 52-week high, while its distance from the 52-week low is 71.43%. The stock’s price range over this timeframe has been between $1.12 and $4.20. The shares of the Healthcare sector company recorded a trading volume of approximately 0.98 million for the day, which was comparatively higher than the average daily volume of 0.29 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Inhibikase Therapeutics Inc (IKT) has experienced a quarterly decline of -29.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 133.17M and boasts a workforce of 8 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.34, with a change in price of +0.56. Similarly, Inhibikase Therapeutics Inc recorded 448,853 in trading volume during the last 100 days, posting a change of +41.18%.

IKT Stock Stochastic Average

The raw stochastic average for Inhibikase Therapeutics Inc over the last 50 days is presently at 6.94%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 0.63%. Further, the company’s Stochastic %K and %D values for the last 20 days were 16.52% and 20.99%, respectively.

Most Popular